Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Simultaneous TAE and Ablation vs Sequential TACE and Ablation for Large HCC
NCT02964260Unknown
- Sponsor
- Sun Yat-sen University
- Start
- May 2016
- Primary completion
- Dec 2022
- Countries
- 1
01
Overview
Randomised, open-label trial (2 arms), sponsored by Sun Yat-sen University. Primary endpoint: Overall Survival at 3 years. Status: unknown.
Beyond the preview
Go deeper on NCT02964260.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02964260.